Caption Management’s Zymeworks ZYME Stock Holding History

Caption Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,200	Closed	-$238K	–	2002
2021 Q3	$238K	Buy	+8,200	New	+$273K	﹤0.01%	1319

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Caption Management's ZYME Position: Q4 2021 in Review

Caption Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 8,200 shares — an estimated $238K sold.

Caption Management first reported a position in ZYME in Q3 2021 and held it in 1 quarter. The position peaked at $238K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

Caption Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
Caption Management sold 8,200 Zymeworks shares in Q4 2021, an estimated $238K.
Caption Management first reported a position in Zymeworks in Q3 2021 and held it in 1 quarter.
Caption Management's Zymeworks position peaked at $238K in Q3 2021.
114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.